Nature: Oligo-astheno-teratozoospermia in mice lacking Cnot7, a regulator of retinoid X receptor beta
Oligo-astheno-teratozoospermia in mice lacking Cnot7, a regulator of retinoid X receptor beta
pharmaphorum: Innovative direct delivery strategies to unlock oligonucleotide therapeutics for CNS disorders
Oligonucleotide (oligo) therapies have been in development for decades. Recent advances in molecular design, chemistry, delivery systems, targeted delivery, reduced immunogenicity, and enhanced ...
Business Wire: Oligonucleotide Synthesis Market Research Report 2025 with Executive and Consultant Guides, & Profiles of 65+ Companies - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Oligonucleotide Synthesis Market: Forecast by Oligo Length, Application, Category, Type, Product, and Region, with Executive and Consultant Guides" report has been added ...
Oligonucleotide Synthesis Market Research Report 2025 with Executive and Consultant Guides, & Profiles of 65+ Companies - ResearchAndMarkets.com
Oligo Security launched out of stealth on Wednesday with its runtime application security platform for detecting vulnerabilities in open source components. Oligo generates a dynamic bill of materials ...
SiliconANGLE: Israeli cybersecurity startup Oligo launches out of stealth with $28M in funding
Israeli cybersecurity startup Oligo Security today launched out of stealth mode and announced that it has raised $28 million for its runtime application security and observability solution. The ...
Israeli cybersecurity startup Oligo launches out of stealth with $28M in funding
Market research figures compiled by Agilent Technologies reveal that in 2009, $407 million in direct financing was targeted to the development of oligonucleotide therapeutics in the U.S. This figure ...